Back
PFAPA syndrome: a review on treatment and outcome.
Journal article

PFAPA syndrome: a review on treatment and outcome.

  • Vanoni F Pediatric Department of Southern Switzerland, Ospedale Regionale di Bellinzona e Valli, Bellinzona, 6500, Switzerland. federica.vanoni@eoc.ch.
  • Theodoropoulou K Unité Romande d'Immuno-rhumatologie Pédiatrique (URIRP), Département Femme-Mère-Enfant (DFME), CHUV, University of Lausanne, Rue du Bugnon 46, Lausanne, 1011, Switzerland.
  • Hofer M Unité Romande d'Immuno-rhumatologie Pédiatrique (URIRP), Département Médico - Chirurgical de Pédiatrie (DFME), CHUV, University of Lausanne, Rue du Bugnon 46, Lausanne, 1011, Switzerland.
  • 2016-06-29
Published in:
  • Pediatric rheumatology online journal. - 2016
Colchicine
Glucocorticoids
PFAPA outcome
PFAPA treatment
Tonsillectomy
Adolescent
Child
Colchicine
Disease Management
Fever
Glucocorticoids
Humans
Lymphadenitis
Neck
Periodicity
Pharyngitis
Stomatitis, Aphthous
Syndrome
Tonsillectomy
Tubulin Modulators
English The syndrome of periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA syndrome) is the most common cause of periodic fever in childhood. The current pharmacological treatment includes corticosteroids, which usually are efficacious in the management of fever episodes, colchicine, for the prophylaxis of febrile episodes, and other medication for which efficacy has not been proven so far. Tonsillectomy is an option for selected patients. Usually PFAPA syndrome resolves during adolescence, but there is increasing evidence that this condition may persist into adulthood.
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/248391
Statistics
Document views: 17 File downloads: